Showing results (11-20 of 47) with videos related to
Sort By:
Pageof 5
Haematologica|June 21, 2006
Corticosteroids can reverse severe imatinib-induced hepatotoxicityDario Ferrero, Enrico Maria Pogliani, Giovanna Rege-Cambrin, et al.Annals of Hematology|April 8, 2014
Survival improvement of poor-prognosis AML/MDS patients by maintenance treatment with low-dose chemotherapy and differentiating agentsDario Ferrero, Elena Crisà, Filippo Marmont, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 14, 2003
Significant correlation between the degree of WT1 expression and the International Prognostic Scoring System Score in patients with myelodysplastic syndromesDaniela Cilloni, Enrico Gottardi, Francesca Messa, et al.Cancer Biology & Therapy|January 17, 2004
Inhibition of cell survival and invasive potential of colorectal carcinoma cells by the tyrosine kinase inhibitor STI571Graziella Bellone, Dario Ferrero, Anna Carbone, et al.Annals of Hematology|February 11, 2010
A retrospective study on 226 polycythemia vera patients: impact of median hematocrit value on clinical outcomes and survival improvement with anti-thrombotic prophylaxis and non-alkylating drugsElena Crisà, Ermanno Venturino, Roberto Passera, et al.Cancers|July 14, 2023
Modern Risk Stratification of Acute Myeloid Leukemia in 2023: Integrating Established and Emerging Prognostic FactorsEleonora Boscaro, Irene Urbino, Federica Maria Catania, et al.Current Treatment Options in Oncology|April 26, 2023
Thrombosis in Acute Myeloid Leukemia: Pathogenesis, Risk Factors and Therapeutic ChallengesMatteo Olivi, Federica Di Biase, Giuseppe Lanzarone, et al.Experimental Hematology|March 24, 2007
Long-term lymphoma survivors following high-dose chemotherapy and autograft: evidence of permanent telomere shortening in myeloid cells, associated with marked reduction of bone marrow hematopoietic stem cell reservoirAlberto Rocci, Irene Ricca, Chiara Dellacasa, et al.Cancers|October 23, 2021
Evolving Therapeutic Approaches for Older Patients with Acute Myeloid Leukemia in 2021Irene Urbino, Carolina Secreto, Matteo Olivi, et al.British Journal of Haematology|July 10, 2018
The use of erythropoiesis-stimulating agents is safe and effective in the management of anaemia in myelofibrosis patients treated with ruxolitinibElena Crisà, Daniela Cilloni, Elena M Elli, et al.Pageof 5